Help! Please Register

  The Fungi

  Introduction
  Descriptions
  Synonyms
  Image Bank
  Lecture Bank
  Video Bank


  Mycoses

  Introduction
  Human
  Veterinary
  Environmental
   Industrial
  Agricultural
  MSG


  Drugs

  Introduction
  Medical
  Veterinary
  Environmental
   Industrial
  Agricultural


  Laboratory

  Introduction
  Susceptibility
  MIC Database
  Procedures
  Histopathology


  Education &
  Tools

  Introduction
  Abbreviations
  Links
  CME
  Conference
   Highlights
  Bibliography
  Glossary
  Good Books
  Events Calendar


  About Us

  Introduction
  Our Mission
  Editorial Board
  Editorial Staff
  Supporters
  Contributors
  Legal Stuff
  Privacy Policy
  Kudos


  The Fungi

  Introduction
  Descriptions
  Synonyms
  Image Bank
  Lecture Bank
  Video Bank



This page updated:
1/27/2007 9:23:00 AM


DoctorFungus - All Rights Reserved © 2007 Copyright
& Privacy Policy


Site built and designed for doctorfungus by Webillustrated



You are here: The Fungi > Descriptions >


Blastomyces sp.
(described by van Tieghem in 1876)

Say Me

Taxonomic Classification

Kingdom: Fungi
Phylum: Ascomycota
Class: Euascomycetes
Order: Onygenales
Family: Onygenaceae
Genus: Blastomyces

Description and Natural Habitats

Blastomyces dermatitidis is a thermally dimorphic fungus and a probable saprobe of the soil. It specifically inhabits decaying wood material. Blastomyces dermatitidis is very rarely isolated as a natural habitat. Isolation from the environment is most likely when the sample contains soil and is rich in organic material such as animal feces, plant fragments, insect remains, and dust. If the substrate is moist, lacks exposure to direct sunlight, contains organic debris, and has a pH of less than 6.0, isolation of Blastomyces dermatitidis is probable. It is endemic in North America. Mississippi, Ohio and Missouri valleys are the geographic locations with highest incidence of infections due to Blastomyces dermatitidis. African type Blastomyces dermatitidis strains isolated from cases in Africa also exist. It was demonstrated that African type strains are not identical with the North American strains. These two groups most probably constitute two distinct serotypes of Blastomyces dermatitidis showing geographic diversity. They have common and varying antigens [1207, 1480].

The sexual state (teleomorph) of Blastomyces dermatitidis belongs to the family Onygenaceae and is referred to as Ajellomyces dermatitidis. Ascospores are the sexual spores produced by this genus.

Species

Blastomyces dermatitidis is the only species included in the genus Blastomyces.

Pathogenicity and Clinical Significance

It is the causative agent of blastomycosis which is one of the true systemic (endemic) mycoses. Cutaneous and systemic (disseminated) blastomycosis are the two clinical forms of the disease. Blastomycosis in general is acquired by inhalation and initially presents with a pulmonary infection which may later disseminate to other organs and systems. Primary cutaneous infection due to direct inoculation of the fungus into the skin is also likely. Hematogenous spread of the organism results in infection of skin, bones, kidneys and male urogenital system. Blastomycosis of the central nervous system (CNS), eyes, larynx, paranasal sinuses, tongue, adrenal glands, uterus, ovaries, gastrointestinal tract, liver and spleen have so far been reported. Otitis media, resulting in cranial osteomyelitis may also develop. Reactivation blastomycosis and subclinical, self-limited infections have been defined [718, 1106, 1590].

Although Blastomyces dermatitidis is a pathogenic fungus and blastomycosis occurs mainly in immunocompetent hosts [528], it may also effect immunocompromised patients, indicating that Blastomyces dermatitidis has now emerged as an opportunistic pathogen [1716].

Blastomyces dermatitidis can also infect dogs. Canine blastomycosis has a similar pathogenesis to human blastomycosis. Dogs are infected by inhaling the infectious particles and they are good indicators of the existence of Blastomyces dermatitidis in the nearby environment. However, there seems to be no correlation between the existence of dogs with blastomycosis and emergence of human cases in a defined environmental area. Also, there is no evidence of animal-to-human transmission of the disease [462].

Macroscopic Features

Being a thermally dimorphic fungus, Blastomyces dermatitidis behaves diversely at different temperatures. The morphology of the fungus is mould-like at 25°C and yeast-like at 37°C. Although the demonstration of conversion from the mycelial form to yeast form is favorable for definitive identification of Blastomyces dermatitidis, it remains possible only for few isolates pathogenic to humans. Other ways of verification of the identification are by use of exoantigen test, direct flourescent antibody and nucleic acid probes. Below are the macroscopic features of the fungus [462, 1295, 2144]:

1. At 25°C
The growth rate is slow to moderately rapid. The colony diameter is 0.5 to 3 cm following incubation for 7 days on potato glucose agar. The texture is membranous and downy to woolly. The surface color is white to beige and reverse is pale to brownish.

2. At 37°C
Conversion to a yeast form at 37°C usually requires inoculation onto an enriched medium. The growth rate is slow to moderately rapid. The colony diameter is 0.5 to 3 cm following incubation for 7 days. The texture is typically creamy and yeast-like. It appears granular to verrucose on the surface. The color of the colony is white to beige.

The classical way to isolate Blastomyces dermatitidis from environmental sources is by animal inoculation techniques. More recently, an in vitro method has also been described and used for isolation of the fungus from a woodpile in north central Wisconsin. In this in vitro method, the environmental material or soil to be tested is placed in a neutral aqueous solution containing allantoin, tween 80, potassium phosphate, magnesium sulphate, penicillin and streptomycin and is incubated at 37°C for 22 days. Following this step, a small amount of the solution (100 µl) is plated onto yeast-extract phosphate agar and incubated at 20°. After the isolation of Blastomyces dermatitidis mould colonies on yeast-extract phosphate agar, the colonies are plated onto brain-heart infusion agar to demonstrate the conversion to yeast phase [202].

Microscopic Features

Similar to the macroscopic morphology, microscopic appearance of the fungus also depends on the temperature of isolation [462, 1295, 2144]:

1.At 25°C
Septate hyaline hyphae and unbranched short conidiophores are observed. Conidiophores arise at right angles to the vegetative hyphae. The conidia are hyaline and unicellular. They are solitary and pyriform to globose in shape.

2. At 37°C
After incubation at 37°C on an enriched medium or in infected tissue sections, the fungus appears as budding yeast cells. The yeast cells (8-12 µm in diameter) typically have double-contoured refractile walls and a broad base attaching the bud to the parent cell. These blastoconidia are globose in appearance.

Histopathologic Features

Although the yeast cells are the major fungal structures found in the infected tissues, mycelial forms of Blastomyces dermatitidis are also observed occasionally. H&E staining method is favorable to evaluate the host tissue reaction. However, Blastomyces dermatitidis may be difficult to visualize in sections stained with H&E. Gomori's methenamine silver stain (GMS) and periodic acid-Schiff (PAS) can readily visualize the fungus. Application of both GMS and H&E stain enables the detection of both host tissue reaction and the fungal cells effectively. GMS stains the cell wall deep black and interior of the yeast cell rose-colored, with a light green background. PAS stains the fungus red and the background pink or light green, depending on the counterstain used. The yeast cells may be small (2-10 µm in diameter) or large (25-40 µm in diameter). When present, hyphae are short, hyaline, and septate [299, 462].

Polymorphonuclear leukocytes and a granulomatous reaction is observed in the infected tissue. Polymorphonuclear infiltration predominates in early lesions, while a granulomatous reaction and multinucleated giant cells appear later. The yeast cells may be located free or inside the giant cells. Abscess formation may be observed [462].

Compare to

Chrysosporium, Emmonsia, Scedosporium, Paracoccidioides [462, 1295, 2144].

Key Features for Differentiation

The mould phase of Blastomyces dermatitidis resembles Chrysosporium, Emmonsia, and Scedosporium. However, the latter three are not dimorphic and do not transform to yeast phase at 37°C. Besides, Chrysosporium but not Blastomyces dermatitidis produces arthroconidia.

Some Paracoccidioides brasiliensis isolates may give false positive results with the DNA probes used for identification of Blastomyces dermatitidis.

Laboratory Precautions

Blastomyces dermatitidis is potentially dangerous and requires biological safety cabinet for all manipulations.

Susceptibility

In vitro susceptibility testing procedures have not been yet standardized for Blastomyces dermatitidis as well as other thermally dimorphic fungi, except for mycelial phase of Sporothrix schenckii. However, there are reports on in vitro activity of some antifungal agents against Blastomyces. In general, amphotericin B, ketoconazole and itraconazole are highly active. In contrast, fluconazole MICs against Blastomyces are unacceptably high. The novel agents, voriconazole, posaconazole, VER-002, and caspofungin appear active against Blastomyces [422, 603, 683, 1338, 2492].

Amphotericin B, ketoconazole, and itraconazole are effective in treatment of blastomycosis. Amphotericin B should be preferred particularly in immunocompromised patients. On the other hand, mild pulmonary blastomycosis may clear spontaneously and not require antifungal therapy. Surgical excision of pulmonary lesions may be indicated in some cases in addition to antifungal therapy [1371, 1716].

For MICs of various antifungal drugs for Blastomyces dermatitidis, see our susceptibility database.

Search

PubMed

Nucleotides

GenBank



Blastomyces dermatitidis
One-celled blastoconidia produced on short conidiophores are typical of Blastomyces dermatitidis at 25°C
KOH blastomyces dermatitidis yeasts
Yeast phase, KOH preparation
Yeast phase
Yeast phase, KOH preparation



References

202. Baumgardner, D. J., and D. P. Paretsky. 1999. The in vitro isolation of Blastomyces dermatitidis from a woodpile in North central Wisconsin, USA. Med. Mycol. 37:163-168.

299. Bottone, E. J., M. Horga, and J. Abrams. 1999. "Giant" blastoconidia of Candida albicans: Morphologic presentation and concepts regarding their production. Diagn Microbiol Infect Dis. 34:27-32.

422. Chapman, S. W., P. D. Rogers, M. G. Rinaldi, and D. C. Sullivan. 1998. Susceptibilities of clinical and laboratory isolates of Blastomyces dermatitidis to ketoconazole, itraconazole, and fluconazole. Antimicrob. Agents Chemother. 42:978-980.

462. Collier, L., A. Balows, and M. Sussman. 1998. Topley & Wilson's Microbiology and Microbial Infections, 9th ed, vol. 4. Arnold, London, Sydney, Auckland, New York.

528. De Groote, M. A., R. Bjerke, H. Smith, and I. L. Rhodes. 2000. Expanding Epidemiology of Blastomycosis: Clinical Features and Investigation of 2 Cases in Colorado. Clin Infect Dis. 30:582-584.

603. Dixon, D. M., G. E. Wagner, S. Shadomy, and H. J. Shadomy. 1978. In vitro comparison of the antifungal activities of R34,000, miconazole and amphotericin B. Chemotherapy. 24:364-7.

683. Espinel-Ingroff, A. 1998. Comparison of in vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts. J Clin Microbiol. 36:2950-2956.

718. Farr, R. C., G. Gardner, J. D. Acker, J. M. Brint, L. F. Haglund, M. Land, J. B. Schweitzer, and B. C. West. 1992. Blastomycotic cranial osteomyelitis. Am J Otol. 13:582-6.

1106. Iwen, P. C., L. Sigler, S. Tarantolo, D. A. Sutton, M. G. Rinaldi, R. P. Lackner, D. I. McCarthy, and S. H. Hinrichs. 2000. Pulmonary infection caused by Gymnascella hyalinospora in a patient with acute myelogenous leukemia. J Clin Microbiol. 38:375-381.

1207. Klein, B. S., B. D. Aizenstein, and L. H. Hogan. 1997. African strains of Blastomyces dermatitidis that do not express surface adhesin WI-1. Infect Immun. 65:1505-9.

1295. Larone, D. H. 1995. Medically Important Fungi - A Guide to Identification, 3rd ed. ASM Press, Washington, D.C.

1338. Li, R. K., M. A. Ciblak, N. Nordoff, L. Pasarell, D. W. Warnock, and M. R. McGinnis. 2000. In vitro activities of voriconazole, itraconazole, and amphotericin B against Blastomyces dermatitidis, Coccidioides immitis and Histoplasma capsulatum. Antimicrob. Agents Chemother. 44:1734-1736.

1371. Lortholary, O., D. W. Denning, and B. Dupont. 1999. Endemic mycoses: a treatment update. J Antimicrob Chemother. 43:321-331.

1480. McCullough, M. J., A. F. DiSalvo, K. V. Clemons, P. Park, and D. A. Stevens. 2000. Molecular epidemiology of Blastomyces dermatitidis. Clin Infect Dis. 30:328-335.

1590. Mounts, A., and G. S. Deepe. 1998. Simultaneous infection with Blastomyces dermatitidis and Cryptococcus neoformans. Med Mycol. 36:47-50.

1716. Pappas, P. G., J. C. Pottage, W. G. Powderly, V. J. Fraser, C. W. Stratton, S. McKenzie, M. L. Tapper, H. Chmel, F. C. Bonebrake, R. Blum, and et al. 1992. Blastomycosis in patients with the acquired immunodeficiency syndrome. Ann. Intern. Med. 116:847-853.

2144. St-Germain, G., and R. Summerbell. 1996. Identifying Filamentous Fungi - A Clinical Laboratory Handbook, 1st ed. Star Publishing Company, Belmont, California.

2492. Zhanel, G. G., J. A. Karlowsky, G. A. J. Harding, T. V. Balko, S. A. Zelenitsky, M. Friesen, A. Kabani, M. Turik, and D. J. Hoban. 1997. In vitro activity of a new semisynthetic echinocandin, LY-303366, against systemic isolates of Candida species, Cryptococcus neoformans, Blastomyces dermatitidis, and Aspergillus species. Antimicrob. Agents Chemother. 41:863-865.



  Home | Image Bank | Lecture Bank | Knowledgebase | Site Map | Contact Us |
The Fungi | Mycoses | Drugs |
Laboratory | Education & Tools | About Us

  bttm_banner_indv2_02[1].gif